Wu Hulin, Miao Hongyu, Xue Hongqi, Topham David J, Zand Martin
Department of Biostatistics and Computational Biology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 630, Rochester, New York 14642.
David H. Smith Center for Vaccine Biology & Immunology, Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, NY, 14642.
Stat Biosci. 2015 May 1;7(1):147-166. doi: 10.1007/s12561-014-9108-2.
Influenza A virus (IAV) infection continues to be a global health threat, as evidenced by the outbreak of the novel A/California/7/2009 IAV strain. Previous flu vaccines have proven less effective than hoped for emerging IAV strains, indicating a more thorough understanding of immune responses to primary infection is needed. One issue is the difficulty in directly measuring many key parameters and variables of the immune response. To address these issues, we considered a comprehensive workflow for statistical inference for ordinary differential question (ODE) models with partially observed variables and time-varying parameters, including identifiability analysis, two-stage and NLS estimation, and model selection etc‥ In particular, we proposed a novel one-step method to verify parameter identifiability and formulate estimating equations simultaneously. Thus, the pseudo-LS method can now deal with general ODE models with partially observed state variables for the first time. Using this workflow, we verified the relative significance of various immune factors to virus control, including target epithelial cells, cytotoxic T-lymphocyte (CD8+) cells and IAV specific antibodies (IgG and IgM). Factors other than cytotoxic T-lymphocyte (CTL) killing contributed the most to the loss of infected epithelial cells, though the effects of CTL are still significant. IgM antibody was found to be the major contributor to neutralization of free infectious viral particles. Also, the maximum viral load, which correlates well with mortality, was found to depend more on viral replication rates than infectivity. In contrast to current hypotheses, the results obtained via our methods suggest that IgM antibody and viral replication rates may be worth of further explorations in vaccine development.
甲型流感病毒(IAV)感染仍然是全球健康威胁,新型A/加利福尼亚/7/2009 IAV毒株的爆发就是明证。事实证明,先前的流感疫苗对新出现的IAV毒株的效果不如预期,这表明需要更全面地了解对初次感染的免疫反应。一个问题是直接测量免疫反应的许多关键参数和变量存在困难。为了解决这些问题,我们考虑了一个用于具有部分观测变量和时变参数的常微分方程(ODE)模型的统计推断的综合工作流程,包括可识别性分析、两阶段和非线性最小二乘估计以及模型选择等。特别是,我们提出了一种新颖的一步法来同时验证参数可识别性并制定估计方程。因此,伪最小二乘法现在首次能够处理具有部分观测状态变量的一般ODE模型。使用这个工作流程,我们验证了各种免疫因素对病毒控制的相对重要性,包括靶上皮细胞、细胞毒性T淋巴细胞(CD8 +)细胞和IAV特异性抗体(IgG和IgM)。除细胞毒性T淋巴细胞(CTL)杀伤作用外的其他因素对感染上皮细胞的损失贡献最大,不过CTL的作用仍然很显著。发现IgM抗体是中和游离感染性病毒颗粒的主要因素。此外,发现与死亡率密切相关的最大病毒载量更多地取决于病毒复制率而非感染性。与当前假设相反,通过我们的方法获得的结果表明,IgM抗体和病毒复制率在疫苗开发中可能值得进一步探索。